Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07403201

The Effect of Therapy Combination in PCOS With Dlbs 3233

The Effect of Combination Therapy Dlbs 3233 and Clomifen Citrate vs Clomifen Citrate on Homa ir, Maturation Follicle, and Menstrual Cycle in PCOS Cases at Muhammadiyah Asri Medical Center Hospital

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Inlacinpenelitian · Academic / Other
Sex
Female
Age
45 Years
Healthy volunteers
Not accepted

Summary

The effect of combination therapy dlbs 3233 and clomifen citrate vs clomifen citrate on homa ir, maturation follicle, and menstrual cycle in PCOS cases at Muhammadiyah Asri Medical Center Hospital

Detailed description

to know the effect of combination dlbs 3233 theraphy and clomifen citrat in cases PCOS to control menstrual cycle and weight loss

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTdlbs 3233 , clomifen citratcombination theraphy

Timeline

Start date
2021-12-15
Primary completion
2026-01-31
Completion
2026-01-31
First posted
2026-02-11
Last updated
2026-02-11

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT07403201. Inclusion in this directory is not an endorsement.

The Effect of Therapy Combination in PCOS With Dlbs 3233 (NCT07403201) · Clinical Trials Directory